Preliminary studies show conolidine may inhibit certain ion channels, minimizing neuronal excitability and limiting discomfort signals. This system is especially suitable in neuropathic soreness, in which abnormal signaling leads to persistent distress. On top of that, conolidine appears to impact G protein-coupled receptor (GPCR) pathways integral